Literature DB >> 17846265

Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.

J Mimi Boer Castelo1, Maureen G Courtney, Rebecca J Melrose, Chantal E Stern.   

Abstract

BACKGROUND: Documented death and dysfunction of basal ganglia cells in patients seropositive for human immunodeficiency virus (HIV) suggest that the virus may cause structural compromise to these regions.
OBJECTIVES: To examine subcortical volumes in nondemented patients seropositive for HIV (HIV+) by means of a novel automated neuroanatomic morphometric analysis tool, and to investigate relationships among cognitive function, immune health, and subcortical volumes. DESIGN AND
SETTING: Cross-sectional study of subcortical morphometry and cognitive function conducted at the Boston University Center for Memory and Brain and the Massachusetts General Hospital Athinoula A. Martinos Center for Biomedical Imaging. PATIENTS: Twenty-two nondemented HIV+ patients and 22 age- and education-matched healthy control participants. MAIN OUTCOME MEASURES: Subcortical segmentation volumes, neuropsychological performance, and immunological variables.
RESULTS: Nondemented HIV+ patients demonstrated relative and isolated putamen hypertrophy compared with control participants. Putamen volume enlargement in HIV+ patients was related to motor slowing and immune status, such that higher CD4 lymphocyte levels were associated with larger putamen volumes. There were no other subcortical volume differences between the groups.
CONCLUSIONS: This study suggests that basal ganglia hypertrophy accompanies HIV-related mild cognitive compromise. These findings may represent a structural imaging parallel to functional imaging studies demonstrating basal ganglia hypermetabolism in HIV+ patients with mild cognitive compromise and early HIV-associated brain disease.

Entities:  

Mesh:

Year:  2007        PMID: 17846265     DOI: 10.1001/archneur.64.9.1275

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  37 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

Review 2.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.

Authors:  Uraina S Clark; Ronald A Cohen; Lawrence H Sweet; Assawin Gongvatana; Kathryn N Devlin; George N Hana; Michelle L Westbrook; Richard C Mulligan; Beth A Jerskey; Tara L White; Bradford Navia; Karen T Tashima
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

4.  Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.

Authors:  April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

5.  Mapping mental number line in physical space: vertical and horizontal visual number line orientation in asymptomatic individuals with HIV.

Authors:  Yelena Bogdanova; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2008-06-04       Impact factor: 3.139

6.  Subcortical shape and volume abnormalities in an elderly HIV+ cohort.

Authors:  Benjamin S C Wade; Victor Valcour; Edgar Busovaca; Pardis Esmaeili-Firidouni; Shantanu H Joshi; Yalin Wang; Paul M Thompson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-17

7.  Progressive brain atrophy in chronically infected and treated HIV+ individuals.

Authors:  Talia M Nir; Neda Jahanshad; Christopher R K Ching; Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; Hei Y Lam; Xue Hua; Jianhui Zhong; Tong Zhu; Michael J Taylor; Thomas B Campbell; Eric S Daar; Elyse J Singer; Jeffry R Alger; Paul M Thompson; Bradford A Navia
Journal:  J Neurovirol       Date:  2019-02-14       Impact factor: 2.643

8.  Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.

Authors:  Adolf Pfefferbaum; David A Rogosa; Margaret J Rosenbloom; Weiwei Chu; Stephanie A Sassoon; Carol A Kemper; Stanley Deresinski; Torsten Rohlfing; Natalie M Zahr; Edith V Sullivan
Journal:  Neurobiol Aging       Date:  2014-01-13       Impact factor: 4.673

9.  Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.

Authors:  Adarsh M Kumar; J B Fernandez; Elyse J Singer; Deborah Commins; Drenna Waldrop-Valverde; Raymond L Ownby; Mahendra Kumar
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

10.  Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia.

Authors:  Li Zhou; Rejane Rua; Thomas Ng; Valentina Vongrad; Yung S Ho; Carolyn Geczy; Kenneth Hsu; Bruce J Brew; Nitin K Saksena
Journal:  BMC Infect Dis       Date:  2009-12-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.